China Resources Double-Crane Pharmaceutical Co Ltd (600062) — Cash Flow Quality Index
China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Cash Flow Quality Index of 1.30x as of September 2025. Operating cash flow of CN¥487.90 Million exceeds net income of CN¥374.04 Million, indicating high earnings quality where cash backs reported profits. Explore China Resources Double-Crane Pharmaceuti (600062) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China Resources Double-Crane Pharmaceutical Co Ltd Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for China Resources Double-Crane Pharmaceutical Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see China Resources Double-Crane Pharmaceuti cash flow conversion.
Annual Cash Flow Quality Index for China Resources Double-Crane Pharmaceutical Co Ltd (1998–2024)
Year-by-year earnings quality comparison for China Resources Double-Crane Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.11x | CN¥1.83 Billion | CN¥1.65 Billion | ▼ -11.2% |
| 2023 | 1.25x | CN¥1.65 Billion | CN¥1.33 Billion | ▲ +12.8% |
| 2022 | 1.10x | CN¥1.34 Billion | CN¥1.22 Billion | ▼ -20.0% |
| 2021 | 1.38x | CN¥1.34 Billion | CN¥972.13 Million | ▲ +2.8% |
| 2020 | 1.34x | CN¥1.36 Billion | CN¥1.01 Billion | ▼ -0.6% |
| 2019 | 1.35x | CN¥1.44 Billion | CN¥1.07 Billion | ▼ -9.1% |
| 2018 | 1.48x | CN¥1.47 Billion | CN¥989.45 Million | ▲ +10.3% |
| 2017 | 1.35x | CN¥1.19 Billion | CN¥882.10 Million | ▲ +29.0% |
| 2016 | 1.04x | CN¥771.25 Million | CN¥739.25 Million | ▼ -1.1% |
| 2015 | 1.05x | CN¥701.35 Million | CN¥664.82 Million | ▼ -20.2% |
| 2014 | 1.32x | CN¥718.38 Million | CN¥543.66 Million | ▲ +111.3% |
| 2013 | 0.63x | CN¥546.24 Million | CN¥873.44 Million | ▼ -0.4% |
| 2012 | 0.63x | CN¥396.05 Million | CN¥630.55 Million | ▼ -32.2% |
| 2011 | 0.93x | CN¥511.53 Million | CN¥552.52 Million | ▼ -3.2% |
| 2010 | 0.96x | CN¥509.67 Million | CN¥533.00 Million | ▲ +29.6% |
| 2009 | 0.74x | CN¥342.01 Million | CN¥463.45 Million | ▼ -11.8% |
| 2008 | 0.84x | CN¥331.71 Million | CN¥396.46 Million | ▲ +62.6% |
| 2007 | 0.51x | CN¥235.46 Million | CN¥457.61 Million | ▼ -69.6% |
| 2006 | 1.69x | CN¥303.71 Million | CN¥179.22 Million | ▲ +130.3% |
| 2005 | 0.74x | CN¥139.78 Million | CN¥189.97 Million | ▼ -74.5% |
| 2003 | 2.89x | CN¥148.94 Million | CN¥51.55 Million | ▲ +200.2% |
| 2002 | 0.96x | CN¥140.63 Million | CN¥146.15 Million | ▲ +10.6% |
| 2001 | 0.87x | CN¥141.01 Million | CN¥162.05 Million | ▼ -30.2% |
| 2000 | 1.25x | CN¥172.81 Million | CN¥138.60 Million | ▼ -28.7% |
| 1999 | 1.75x | CN¥131.54 Million | CN¥75.25 Million | ▲ +875.2% |
| 1998 | -0.23x | CN¥-13.78 Million | CN¥61.13 Million | — |